Addiction Medicine: Tobacco Use Disorder
- PMID: 39556472
Addiction Medicine: Tobacco Use Disorder
Abstract
The number one cause of preventable disease, disability, and death in the United States is tobacco use. According to data from the National Health Interview Survey, 18.7% of US adults (46 million people) currently use a tobacco product. Smoking causes lung, laryngeal, hepatocellular, and colorectal cancers and possibly breast cancer. Nicotine is the highly addictive component of tobacco that releases dopamine when it binds to alpha-4 beta-2 nicotinic acetylcholine receptors in the brain. This produces reward sensations that become associated with specific behaviors and relieves stress and negative emotions. Public policy changes, behavioral interventions, and pharmacologic approaches have been shown to reduce tobacco use. Combining behavior therapy with pharmacotherapy increases cessation rates. The US Food and Drug Administration has approved five nicotine replacement therapies and two no-nicotine oral medications to assist with smoking cessation. Medications are categorized as controllers or relievers based on their pharmacokinetics. Nicotine replacement therapy delivers lower amounts of nicotine and needs to be titrated to alleviate patient cravings. Varenicline is a selective partial agonist at the alpha-4 beta-2 nicotinic acetylcholine receptor and is recommended over bupropion for smoking cessation.
Written permission from the American Academy of Family Physicians is required for reproduction of this material in whole or in part in any form or medium.
Similar articles
-
Advances in smoking cessation pharmacotherapy: Non-nicotinic approaches in animal models.Neuropharmacology. 2020 Nov 1;178:108225. doi: 10.1016/j.neuropharm.2020.108225. Epub 2020 Aug 3. Neuropharmacology. 2020. PMID: 32758566 Free PMC article. Review.
-
Understanding the implications of the biobehavioral basis of nicotine addiction and its impact on the efficacy of treatment.Expert Rev Respir Med. 2018 Sep;12(9):793-804. doi: 10.1080/17476348.2018.1507736. Epub 2018 Aug 13. Expert Rev Respir Med. 2018. PMID: 30092681 Review.
-
Treatment of Tobacco Smoking: A Review.JAMA. 2022 Feb 8;327(6):566-577. doi: 10.1001/jama.2022.0395. JAMA. 2022. PMID: 35133411 Review.
-
Current treatment options in smoking cessation.Hosp Pract (1995). 2010 Feb;38(1):53-61. doi: 10.3810/hp.2010.02.279. Hosp Pract (1995). 2010. PMID: 20469625
-
Lung Cancer: Smoking Cessation.FP Essent. 2018 Jan;464:11-16. FP Essent. 2018. PMID: 29313652 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical